Medication burden and frailty in older adults with intellectual disability: An observational cross-sectional study.

Pharmacoepidemiology and Drug Safety
Juliette O'ConnellMáire O'Dwyer

Abstract

Recently, efforts have been made to quantify frailty among older adults with intellectual disability (ID). Medication exposure is associated with frailty among older adults without ID. However, there is little research on this association among older adults with ID. The aim of this study was to examine specifically in people with ID the association between frailty and medication exposure, including anticholinergic and sedative medication exposure. Data were drawn from Wave 2 (2013/2014) of the Intellectual Disability Supplement to the Irish Longitudinal Study on Ageing (IDS-TILDA), a nationally representative study of older adults with ID in Ireland. A modified version of Fried's frailty phenotype was constructed. Drug burden measures were polypharmacy, Drug Burden Index (DBI), Anticholinergic Cognitive Burden (ACB) and Sedative Load Model. Multinomial logistic regression was used to calculate odds ratios (ORs) and identify associations between frailty and drug burden. This study included 570 participants with ID. Excessive polypharmacy (use of ≥10 medications) was significantly associated with being pre-frail (P = .017; OR = 2.56; 95% confidence interval [CI] 1.19-5.50) and frail (P < .001; OR 7.13; 95% CI 2.81-18.12), but DBI...Continue Reading

References

Dec 1, 1996·Journal of Clinical Epidemiology·P PeduzziA R Feinstein
Nov 18, 2000·Journal of Intellectual Disability Research : JIDR·K PatjaI Ruoppila
Mar 17, 2001·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·L P FriedUNKNOWN Cardiovascular Health Study Collaborative Research Group
Jun 27, 2002·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·A H BittlesP D Montgomery
Sep 1, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Kenneth RockwoodArnold Mitnitski
Jun 9, 2007·Psychosomatic Medicine·Aron S BuchmanDavid A Bennett
Jul 20, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Kenneth Rockwood, Arnold Mitnitski
Jul 20, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Howard BergmanChristina Wolfson
Nov 15, 2008·Age and Ageing·Ruth E HubbardKen W Woodhouse
Dec 20, 2008·Journal of the American Geriatrics Society·Marc D RothmanThomas M Gill
Feb 22, 2011·The American Journal of Geriatric Pharmacotherapy·Heidi T TaipaleJ Simon Bell
Jul 15, 2011·Neurology·Xiaowei SongKenneth Rockwood
Jul 30, 2011·Journal of the American Geriatrics Society·Maarit S DimitrowSaija N S Leikola
Feb 3, 2012·Clinical Pharmacology and Therapeutics·D GnjidicD G Le Couteur
May 17, 2012·Journal of the American Geriatrics Society·Heleen M EvenhuisMichael A Echteld
Aug 14, 2012·Journal of the American Geriatrics Society·Rose M CollardRichard C Oude Voshaar
Feb 12, 2013·Lancet·Andrew CleggKenneth Rockwood
Mar 12, 2013·Research in Developmental Disabilities·Josje D SchoufourMichael A Echteld
Apr 16, 2013·Research in Developmental Disabilities·Barbara Brehmer-RindererGermain Weber
Aug 21, 2013·Developmental Disabilities Research Reviews·Heleen EvenhuisMichael Echteld
Mar 4, 2014·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Justin P TurnerJ Simon Bell
Jul 22, 2014·International Journal of Surgery·Jan P VandenbrouckeUNKNOWN STROBE Initiative
Dec 2, 2014·Journal of the American Medical Directors Association·Jure PeklarMitja Kos
Dec 31, 2014·Journal of the American Medical Directors Association·Florence MoulisBruno Vellas
Jul 5, 2016·Journal of the American Medical Directors Association·Arjun PoudelRuth E Hubbard
Sep 24, 2016·The British Journal of Psychiatry : the Journal of Mental Science·Máire O'DwyerMartin C Henman
Dec 27, 2016·Journal of the American Geriatrics Society·Kai-Uwe SaumHermann Brenner

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.